Europe’s drug regulator has found a possible link between Johnson & Johnson’s COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.
EU regulator backs use of Johnson & Johnson COVID-19 vaccine despite finding possible link to blood clots
